Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
03:20pm, Monday, 12'th Sep 2022 GlobeNewswire Inc.
NEW YORK and MAINZ, GERMANY, September 12, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 va
BioNTech präsentiert auf ESMO-Kongress weitere ermutigende Daten aus Phase-1/2-Studie mit CAR-T-Programm BNT211 in schwer zu behandelnden soliden Tumoren
02:30pm, Friday, 09'th Sep 2022 GlobeNewswire Inc.
MAINZ, Deutschland, 9. September 2022 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) präsentierte heute positive Follow-up-Daten aus der laufenden klinischen Phase-1/2-Stud
BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO
02:30pm, Friday, 09'th Sep 2022 GlobeNewswire Inc.
MAINZ, Germany, September 9, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today presented positive follow-up data from its ongoing first-in-human Phase 1/2 trial evaluating
BioNTech CEO Ugur Sahin besuchte Israel: Diskussion möglicher Zusammenarbeit bei der Pandemievorsorge und der Entwicklung innovativer Medikamente
06:00am, Wednesday, 07'th Sep 2022 GlobeNewswire Inc.
JERUSALEM, Israel, und MAINZ, Deutschland, 7. September 2022 — BioNTech SE (Nasdaq: BNTX, „BioNTech“) gab heute bekannt, dass Prof. Ugur Sahin, CEO und Mitbegründer von BioNTech, nach Israel ge
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative Medicines
06:00am, Wednesday, 07'th Sep 2022 GlobeNewswire Inc.
JERUSALEM, Israel, and MAINZ, Germany, September 7, 2022 —BioNTech SE (Nasdaq: BNTX) announced today that Prof. Ugur Sahin, CEO and Co-founder of BioNTech, visited Israel to meet with the Minister o
Why Novavax Stock Sank to a New 52-Week Low Today
04:35pm, Tuesday, 06'th Sep 2022 The Motley Fool
The vaccine maker's recent regulatory victories aren't landing with investors.
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
05:08pm, Monday, 05'th Sep 2022 Zacks Investment Research
Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.
Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation
05:45pm, Friday, 02'nd Sep 2022 Zacks Investment Research
The European Medicines Agency's CHMP recommends expanded conditional marketing authorization for Novavax's (NVAX) COVID-19 vaccine as a booster for adults.
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
01:06pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
The Zacks Analyst Blog Highlights Pfizer /BioNTec and Moderna's
11:59am, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer /BioNTec and Moderna are part of The Zacks top Analyst Blog.
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
10:32am, Friday, 02'nd Sep 2022
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters
09:26am, Friday, 02'nd Sep 2022
The CDC green-lighted updated Covid boosters from Pfizer and Moderna, helping vaccine stocks edge higher Friday. The post Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters appeared
FDA Authorizes Pfizer, Moderna's Omicron-Based Boosters
02:48pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) develop the Omicron BA.4/BA.5-adapted bivalent vaccines at the FDA's recommendation.
Pharma Stock Roundup: FDA Authorization of Omicron Boosters, SNY's Xenpozyme & More
02:41pm, Thursday, 01'st Sep 2022 Zacks Investment Research
FDA authorizes Pfizer (PFE) & Moderna's (MRNA) Omicron-aimed COVID vaccines & Sanofi's (SNY) new drug, Xenpozyme.
2 Big Red Flags and 1 Small Green Flag For Pfizer Stock
02:00pm, Thursday, 01'st Sep 2022 The Motley Fool
It has what could become a pair of big problems on its hands.
